TRIM37 and breast cancer: TRIM37 mono-ubiquitinates histone H2A in the MCF-7 breast cancer cell line, and this has been reported to dampen the expression of thousands of genes, including tumors suppressors, thus offering a potential link between TRIM37 overexpression and tumorigenesis (Bhatnagar et al., 2014).